WallStSmart
TWST

Twist Bioscience Corp

NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH

$56.70
-4.14% today

Updated 2026-04-29

Market cap
$3.48B
P/E ratio
P/S ratio
8.88x
EPS (TTM)
$-1.27
Dividend yield
52W range
$23 – $66
Volume
1.2M

Twist Bioscience Corp (TWST) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$2.27M$10.77M$25.43M$54.38M$90.10M$132.33M$203.56M$245.11M$312.97M$376.57M
Revenue growth (YoY)+374.5%+136.2%+113.9%+65.7%+46.9%+53.8%+20.4%+27.7%+20.3%
Cost of revenue$9.42M$24.02M$32.19M$47.43M$61.41M$80.62M$119.33M$155.38M$179.63M$185.57M
Gross profit$-7.15M$-13.25M$-6.76M$6.96M$28.69M$51.71M$84.23M$89.73M$133.35M$191.00M
Gross margin-315.2%-123.1%-26.6%12.8%31.8%39.1%41.4%36.6%42.6%50.7%
R&D$18.23M$19.17M$20.35M$35.68M$43.01M$69.07M$120.31M$106.89M$90.85M$80.28M
SG&A$18.07M$25.96M$42.55M$78.83M$102.07M$133.40M$210.55M$186.84M$218.40M$239.98M
Operating income$-43.66M$-58.48M$-70.56M$-108.85M$-140.08M$-152.73M$-249.02M$-217.16M$-220.83M$-136.26M
Operating margin-1924.0%-543.2%-277.5%-200.1%-155.5%-115.4%-122.3%-88.6%-70.6%-36.2%
EBITDA$-39.11M$-53.10M$-63.95M$-99.77M$-132.09M$-143.91M$-247.05M$-174.15M$-176.71M$-52.10M
EBITDA margin-1723.8%-493.2%-251.5%-183.5%-146.6%-108.7%-121.4%-71.1%-56.5%-13.8%
EBIT$-43.34M$-58.13M$-69.68M$-106.08M$-138.76M$-153.66M$-249.02M$-203.46M$-208.14M$-76.95M
Interest expense$746000.00$905000.00$1.31M$1.29M$787000.00$367000.00$80000.00$5000.00$29000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-44.09M$-59.31M$-71.24M$-107.67M$-139.93M$-152.10M$-217.86M$-204.62M$-208.73M$-77.67M
Net income growth (YoY)-34.5%-20.1%-51.1%-30.0%-8.7%-43.2%+6.1%-2.0%+62.8%
Profit margin-1943.1%-550.8%-280.2%-198.0%-155.3%-114.9%-107.0%-83.5%-66.7%-20.6%